Label Image (Lbl500905611)
Nuvaring Insert, Extended Release
Product Images NDC 50090-5611
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Nuvaring (NDC 50090-5611). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Nuvaring 01)
Chemical Structure (Nuvaring 02)
Figure 2 (Nuvaring 03)
Figure 3 (Nuvaring 04)
description:
The text appears to be discussing different methods of birth control, with some information regarding the likelihood of pregnancy based on the chosen method. There are various options mentioned including injections, intrauterine devices, sterilization, birth control pills, a skin patch, and a vaginal ring. Additionally, there are brief descriptions of some non-hormonal methods, such as abstaining from sex on fertile days or using spermicide. Some statistics are also provided about the rates of pregnancy depending on the method of birth control used, ranging from less than one pregnancy per 100 women per year to as many as 85 or more pregnancies per 100 women.*
Figure 4 (Nuvaring 05)
Figure A, Figure B, Figure C (Nuvaring 06)
Figure D, Figure E (Nuvaring 07)
Figure F (Nuvaring 08)
This text seems to be a list of items that are likely related to reproductive health. Specifically, it mentions the uterus and vagina, which are both part of the female reproductive system. The text also includes the term "NuvaRing®," which is a contraceptive device that is inserted into the vagina. Based on this limited information, it's possible that the text is related to a discussion of reproductive health, contraception, and/or gynecological issues.*
Figure G (Nuvaring 09)
Figure H (Nuvaring 10)
Figure I (Nuvaring 11)
Figure J (Nuvaring 12)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
